Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide
- PMID: 6449369
Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide
Abstract
The purpose of this investigation was to determine whether inhalation of a freon gas mixture, the propellant of the commercial metered-dose aerosols, consisting of freon 11, freon 12, and freon 114, reduces the bronchodilating effects of inhaled salbutamol or ipratropium bromide or causes cardiac arrhythmias in control, asthmatic and bronchitic subjects. FEV1 and flows measured at different lung volumes on the maximal effort expiratoryflow-volume curve were measured during a period of 6 h. Inhalation of freon caused no significant overall reduction in the salbutamol and ipratropium bromide response in any group. Arrhythmias only occurred among the asthmatic and bronchitic patients, and were most frequent after salbutamol. Ventricular extrasystoles occurred in three cases, all after salbutamol and in two of these in combination with freon inhalation. In one patient there was furthermore hyposia and hypercapnia. The combination of the effects of hypoxia, hypercapnia, catecholamines and freon on the heart is therefore a more likely cause of arrhythmia than the effect of freon alone.
Similar articles
-
Maximal expiratory flows and forced vital capacity in normal, asthmatic and bronchitic subjects after salbutamol and ipratropium bromide.Respiration. 1982;43(4):304-16. doi: 10.1159/000194499. Respiration. 1982. PMID: 6213991
-
[Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].Arch Monaldi. 1983 Sep-Dec;38(5-6):241-54. Arch Monaldi. 1983. PMID: 6238579 Clinical Trial. Italian. No abstract available.
-
Salbutamol and ipratropium bromide solution in the treatment of bronchospasm in asthmatic children.Ann Allergy. 1987 Jan;58(1):54-8. Ann Allergy. 1987. PMID: 2948430 Clinical Trial.
-
Use of ipratropium bromide in obstructive lung disease.Clin Pharm. 1988 Sep;7(9):670-80. Clin Pharm. 1988. PMID: 2977109 Review.
-
Intranasal ipratropium: literature abstracts and comments.Rhinol Suppl. 1989;9:37-44. Rhinol Suppl. 1989. PMID: 2534054 Review.
Cited by
-
Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II).Med Toxicol Adverse Drug Exp. 1988 May-Jun;3(3):209-40. doi: 10.1007/BF03259883. Med Toxicol Adverse Drug Exp. 1988. PMID: 3041246 Review. No abstract available.